CA Stock MarketDetailed Quotes

Rakovina Therapeutics Inc (RKV)

Watchlist
  • 0.110
  • -0.010-8.33%
15min DelayMarket Closed Jan 15 16:00 ET
2.33MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rakovina Therapeutics Inc (RKV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
74.05%1.64M
273.76%2.83M
205.82%2.11M
52.61%3.79M
111.49%1.4M
59.78%943.12K
29.22%755.97K
6.92%690.07K
-11.90%2.48M
1.31%661.44K
Selling and administrative expenses
102.00%539.17K
339.38%1.21M
387.78%1.22M
78.48%1.45M
169.61%652.26K
63.34%266.92K
43.07%276.18K
18.41%251.09K
-6.66%810.42K
55.96%241.93K
-General and administrative expense
102.00%539.17K
339.38%1.21M
387.78%1.22M
78.48%1.45M
169.61%652.26K
63.34%266.92K
43.07%276.18K
18.41%251.09K
-6.66%810.42K
55.96%241.93K
Research and development costs
63.02%1.1M
235.98%1.61M
101.74%885.59K
40.07%2.34M
77.98%746.63K
58.42%676.2K
22.40%479.79K
1.30%438.98K
-14.24%1.67M
-15.72%419.51K
Operating profit
-74.05%-1.64M
-273.76%-2.83M
-205.82%-2.11M
-52.61%-3.79M
-111.49%-1.4M
-59.78%-943.12K
-29.22%-755.97K
-6.92%-690.07K
11.90%-2.48M
-1.31%-661.44K
Net non-operating interest income (expenses)
-106.89%-139.75K
-42.40%-91.69K
-9.00%-66.78K
-103.76%-262.72K
-13.19%-69.08K
-19.17%-67.55K
-321.08%-64.39K
-1,605.63%-61.26K
-556.02%-128.94K
-948.55%-61.04K
Non-operating interest income
--0
--0
--0
-73.99%5.82K
--0
-94.11%437
-73.37%1.84K
-2.14%3.98K
-20.88%22.37K
-44.71%3.98K
Non-operating interest expense
105.56%139.75K
38.45%91.69K
2.35%66.78K
77.48%268.54K
6.26%69.08K
6.05%67.99K
198.44%66.22K
--65.25K
--151.31K
--65.01K
Other net income (expenses)
2.54%-460
159.73%218
-157.93%-2.7K
-1,058.94%-21.85K
-6,890.59%-20.06K
-2,384.21%-472
67.03%-365
-121.61%-1.05K
7.14%-1.89K
83.69%-287
Gain on sale of security
2.54%-460
159.73%218
-157.93%-2.7K
-60.80%-3.03K
-334.84%-1.25K
-2,384.21%-472
67.03%-365
-121.61%-1.05K
7.14%-1.89K
83.69%-287
Special income (charges)
----
----
----
---18.82K
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--18.82K
----
----
----
----
----
----
Income before tax
-76.21%-1.78M
-255.41%-2.92M
-189.72%-2.18M
-55.86%-4.07M
-105.88%-1.49M
-56.29%-1.01M
-36.47%-820.72K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Income tax
Earnings from equity interest net of tax
Net income
-76.21%-1.78M
-255.41%-2.92M
-189.72%-2.18M
-55.86%-4.07M
-105.88%-1.49M
-56.29%-1.01M
-36.47%-820.72K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Net income continuous operations
-76.21%-1.78M
-255.41%-2.92M
-189.72%-2.18M
-55.86%-4.07M
-105.88%-1.49M
-56.29%-1.01M
-36.47%-820.72K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Noncontrolling interests
Net income attributable to the company
-76.21%-1.78M
-255.41%-2.92M
-189.72%-2.18M
-55.86%-4.07M
-105.88%-1.49M
-56.29%-1.01M
-36.47%-820.72K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-76.21%-1.78M
-255.41%-2.92M
-189.72%-2.18M
-55.86%-4.07M
-105.88%-1.49M
-56.29%-1.01M
-36.47%-820.72K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Diluted earnings per share
27.27%-0.08
-50.00%-0.18
-100.00%-0.2
-25.00%-0.5
-60.00%-0.16
-10.00%-0.11
-20.00%-0.12
0.00%-0.1
0.00%-0.4
0.00%-0.1
Basic earnings per share
27.27%-0.08
-50.00%-0.18
-100.00%-0.2
-25.00%-0.5
-60.00%-0.16
-10.00%-0.11
-20.00%-0.12
0.00%-0.1
0.00%-0.4
0.00%-0.1
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 74.05%1.64M273.76%2.83M205.82%2.11M52.61%3.79M111.49%1.4M59.78%943.12K29.22%755.97K6.92%690.07K-11.90%2.48M1.31%661.44K
Selling and administrative expenses 102.00%539.17K339.38%1.21M387.78%1.22M78.48%1.45M169.61%652.26K63.34%266.92K43.07%276.18K18.41%251.09K-6.66%810.42K55.96%241.93K
-General and administrative expense 102.00%539.17K339.38%1.21M387.78%1.22M78.48%1.45M169.61%652.26K63.34%266.92K43.07%276.18K18.41%251.09K-6.66%810.42K55.96%241.93K
Research and development costs 63.02%1.1M235.98%1.61M101.74%885.59K40.07%2.34M77.98%746.63K58.42%676.2K22.40%479.79K1.30%438.98K-14.24%1.67M-15.72%419.51K
Operating profit -74.05%-1.64M-273.76%-2.83M-205.82%-2.11M-52.61%-3.79M-111.49%-1.4M-59.78%-943.12K-29.22%-755.97K-6.92%-690.07K11.90%-2.48M-1.31%-661.44K
Net non-operating interest income (expenses) -106.89%-139.75K-42.40%-91.69K-9.00%-66.78K-103.76%-262.72K-13.19%-69.08K-19.17%-67.55K-321.08%-64.39K-1,605.63%-61.26K-556.02%-128.94K-948.55%-61.04K
Non-operating interest income --0--0--0-73.99%5.82K--0-94.11%437-73.37%1.84K-2.14%3.98K-20.88%22.37K-44.71%3.98K
Non-operating interest expense 105.56%139.75K38.45%91.69K2.35%66.78K77.48%268.54K6.26%69.08K6.05%67.99K198.44%66.22K--65.25K--151.31K--65.01K
Other net income (expenses) 2.54%-460159.73%218-157.93%-2.7K-1,058.94%-21.85K-6,890.59%-20.06K-2,384.21%-47267.03%-365-121.61%-1.05K7.14%-1.89K83.69%-287
Gain on sale of security 2.54%-460159.73%218-157.93%-2.7K-60.80%-3.03K-334.84%-1.25K-2,384.21%-47267.03%-365-121.61%-1.05K7.14%-1.89K83.69%-287
Special income (charges) ---------------18.82K------------------0----
-Less:Other special charges --------------18.82K------------------------
Income before tax -76.21%-1.78M-255.41%-2.92M-189.72%-2.18M-55.86%-4.07M-105.88%-1.49M-56.29%-1.01M-36.47%-820.72K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Income tax
Earnings from equity interest net of tax
Net income -76.21%-1.78M-255.41%-2.92M-189.72%-2.18M-55.86%-4.07M-105.88%-1.49M-56.29%-1.01M-36.47%-820.72K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Net income continuous operations -76.21%-1.78M-255.41%-2.92M-189.72%-2.18M-55.86%-4.07M-105.88%-1.49M-56.29%-1.01M-36.47%-820.72K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Noncontrolling interests
Net income attributable to the company -76.21%-1.78M-255.41%-2.92M-189.72%-2.18M-55.86%-4.07M-105.88%-1.49M-56.29%-1.01M-36.47%-820.72K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -76.21%-1.78M-255.41%-2.92M-189.72%-2.18M-55.86%-4.07M-105.88%-1.49M-56.29%-1.01M-36.47%-820.72K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Diluted earnings per share 27.27%-0.08-50.00%-0.18-100.00%-0.2-25.00%-0.5-60.00%-0.16-10.00%-0.11-20.00%-0.120.00%-0.10.00%-0.40.00%-0.1
Basic earnings per share 27.27%-0.08-50.00%-0.18-100.00%-0.2-25.00%-0.5-60.00%-0.16-10.00%-0.11-20.00%-0.120.00%-0.10.00%-0.40.00%-0.1
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -